A continuous decrease of serum CEA was observed in 1 patient with lung cancer.Two patients had SD (1 patient with lung cancer).Clinical and immunological responses were only observed in patients treated with adjuvant use of INF-α and TNF-α. The gene discussed is IFNA17; the disease is lung carcinoma.